Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Veteran's atopic eczema caused frequent flare-ups, requiring daily use of topical corticosteroids and oral doxycycline. The Board found that the condition most closely approximated a rating of 60 percent for constant or near-constant systemic therapy.

The deciding factor: The Veteran's atopic eczema required constant or near-constant use of systemic therapy, including oral doxycycline and topical corticosteroids.

Claimed conditions
atopic eczema
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
60%
Decision date
August 17, 2017
Citation
1733669

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1733669.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.